Prevention of Early Death in Very Elderly Acute Promyelocytic Leukemia Patients Using Lower Induction Doses of All-trans Retinoic Acid.
作者信息
Dalgetty Mark, Dontu Sruthi, Kannan Chandini, Keruakous Amany, Bryan Locke, Kota Vamsi, Jillella Anand
机构信息
Georgia Cancer Center at Augusta University, Augusta, GA, USA.
Medical College of Georgia at Augusta University, Augusta, GA, USA.
出版信息
Mediterr J Hematol Infect Dis. 2025 Sep 1;17(1):e2025066. doi: 10.4084/MJHID.2025.066. eCollection 2025.
Abstract
摘要
相似文献
1
Prevention of Early Death in Very Elderly Acute Promyelocytic Leukemia Patients Using Lower Induction Doses of All-trans Retinoic Acid.使用较低诱导剂量全反式维甲酸预防高龄急性早幼粒细胞白血病患者过早死亡
Mediterr J Hematol Infect Dis. 2025 Sep 1;17(1):e2025066. doi: 10.4084/MJHID.2025.066. eCollection 2025.
2
Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia.全反式维甲酸、三氧化二砷和吉妥单抗奥唑米星治疗急性早幼粒细胞白血病的2期研究长期随访
Cancer. 2025 Jan 1;131(1):e35662. doi: 10.1002/cncr.35662. Epub 2024 Nov 25.
3
All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study.全反式维甲酸治疗急性早幼粒细胞白血病。纽约研究结果。
Ann Intern Med. 1994 Feb 15;120(4):278-86. doi: 10.7326/0003-4819-120-4-199402150-00004.
4
[A case of acute promyelocytic leukemia with NUP98::RARG::LINE-L2a tripartite fusion and the mechanism of resistance to all-trans retinoic acid].一例伴有NUP98::RARG::LINE-L2a三方融合的急性早幼粒细胞白血病及对全反式维甲酸耐药的机制
Zhonghua Yi Xue Za Zhi. 2025 Jul 8;105(25):2120-2123. doi: 10.3760/cma.j.cn112137-20250226-00450.
5
The "retinoic acid syndrome" in acute promyelocytic leukemia.急性早幼粒细胞白血病中的“维甲酸综合征”
Ann Intern Med. 1992 Aug 15;117(4):292-6. doi: 10.7326/0003-4819-117-4-292.
6
Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia.一位年轻女性被诊断出患有急性早幼粒细胞白血病，并在诱导缓解和复发治疗期间接受了治疗，随后成功产下了两个健康的孩子。
J Oncol Pharm Pract. 2020 Dec;26(8):2034-2037. doi: 10.1177/1078155220915764. Epub 2020 Apr 11.
7
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.三氧化二砷在治疗新诊断的急性早幼粒细胞白血病中是必需的。法国-比利时-瑞士 APL 组对一项随机试验（APL2006）的分析。
Haematologica. 2018 Dec;103(12):2033-2039. doi: 10.3324/haematol.2018.198614. Epub 2018 Jul 19.
8
Long-term real-world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all-trans retinoic acid without chemotherapy-a retrospective, single-centre study.三氧化二砷联合全反式维甲酸无化疗治疗急性早幼粒细胞白血病患者的长期真实世界结局——一项回顾性单中心研究
Br J Haematol. 2023 Apr;201(2):249-255. doi: 10.1111/bjh.18618. Epub 2022 Dec 18.
9
All-trans-retinoic acid in acute promyelocytic leukemia.全反式维甲酸在急性早幼粒细胞白血病中的应用
N Engl J Med. 1997 Oct 9;337(15):1021-8. doi: 10.1056/NEJM199710093371501.
10
Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia.氟康唑在体外及急性早幼粒细胞白血病患者中对全反式维甲酸代谢的抑制作用。
Biochem Pharmacol. 1995 Sep 28;50(7):923-8. doi: 10.1016/0006-2952(95)00213-j.
本文引用的文献
1
Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial.急性早幼粒细胞白血病学术社区合作与早期死亡率：ECOG-ACRIN EA9131试验
JAMA Oncol. 2025 Feb 27;11(4):400-7. doi: 10.1001/jamaoncol.2024.7033.
2
Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia.外周血白细胞计数和肿瘤坏死因子-α对急性早幼粒细胞白血病早期死亡的影响。
BMC Cancer. 2023 Jan 7;23(1):27. doi: 10.1186/s12885-022-10499-2.
3
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.医疗机构与社区实践联合管理策略，降低急性早幼粒细胞白血病诱导治疗死亡率。
JCO Oncol Pract. 2021 Apr;17(4):e497-e505. doi: 10.1200/OP.20.00395. Epub 2020 Oct 30.
4
Comparative analysis of causes and predictors of early death in elderly and young patients with acute promyelocytic leukemia treated with arsenic trioxide.三氧化二砷治疗老年和年轻急性早幼粒细胞白血病患者早期死亡原因及预测因素的对比分析。
J Cancer Res Clin Oncol. 2020 Feb;146(2):485-492. doi: 10.1007/s00432-019-03076-x. Epub 2019 Nov 4.
5
Differentiation syndrome in acute promyelocytic leukaemia.急性早幼粒细胞白血病分化综合征。
Br J Haematol. 2019 Oct;187(2):157-162. doi: 10.1111/bjh.16151. Epub 2019 Aug 13.
6
Acute Promyelocytic Leukemia (APL): Comparison Between Children and Adults.急性早幼粒细胞白血病（APL）：儿童与成人的比较
Mediterr J Hematol Infect Dis. 2014 Apr 15;6(1):e2014032. doi: 10.4084/MJHID.2014.032. eCollection 2014.
7
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.全反式维甲酸和三氧化二砷联合治疗急性早幼粒细胞白血病。
N Engl J Med. 2013 Jul 11;369(2):111-21. doi: 10.1056/NEJMoa1300874.
8
Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group.老年急性早幼粒细胞白血病患者的结局：德国急性髓系白血病合作组的研究结果。
Ann Hematol. 2013 Jan;92(1):41-52. doi: 10.1007/s00277-012-1597-9. Epub 2012 Oct 23.
9
The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the pethema group and review of the literature.急性早幼粒细胞白血病患者的分化综合征：Pethema 组的经验和文献复习。
Mediterr J Hematol Infect Dis. 2011;3(1):e2011059. doi: 10.4084/MJHID.2011.059. Epub 2011 Dec 4.
10
Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.尽管采用全反式维甲酸治疗，但急性早幼粒细胞白血病的早期死亡率仍然很高。
Blood. 2011 Aug 4;118(5):1248-54. doi: 10.1182/blood-2011-04-346437. Epub 2011 Jun 8.
Zotero 插件